Perspective Therapeutics, Inc. (CATX)
USD 1.92
(-1.03%)
USD 1.92
(-1.03%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 | 1.63 Million USD | -64.6% |
| 2021 | 4.61 Million USD | -9.86% |
| 2020 | 5.12 Million USD | -0.06% |
| 2019 | 5.12 Million USD | 68.17% |
| 2018 | 3.04 Million USD | 65.42% |
| 2017 | 1.84 Million USD | 119.81% |
| 2016 | 838 Thousand USD | 548.84% |
| 2015 | 129.15 Thousand USD | -22.84% |
| 2014 | 167.39 Thousand USD | 185.2% |
| 2013 | -196.47 Thousand USD | -230.83% |
| 2012 | 150.17 Thousand USD | -78.64% |
| 2011 | 703.2 Thousand USD | -39.24% |
| 2010 | 1.15 Million USD | 59.47% |
| 2009 | 725.79 Thousand USD | 305.42% |
| 2008 | -353.33 Thousand USD | -133.32% |
| 2007 | -151.43 Thousand USD | -177.37% |
| 2006 | -54.59 Thousand USD | 97.0% |
| 2005 | -1.82 Million USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | -100.0% |
| 1996 | 1.16 Million USD | 46.38% |
| 1995 | 795.6 Thousand USD | -3.24% |
| 1994 | 822.27 Thousand USD | 123.51% |
| 1993 | 367.89 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q1 | 462 Thousand USD | 235.88% |
| 2022 Q3 | 254 Thousand USD | -36.97% |
| 2022 Q1 | 414 Thousand USD | -55.29% |
| 2022 Q2 | 403 Thousand USD | -2.66% |
| 2022 FY | 1.63 Million USD | -64.6% |
| 2022 Q4 | -340 Thousand USD | -233.86% |
| 2021 Q3 | 1.44 Million USD | 18.11% |
| 2021 Q1 | 1.02 Million USD | -23.55% |
| 2021 FY | 4.61 Million USD | -9.86% |
| 2021 Q4 | 926 Thousand USD | -35.74% |
| 2021 Q2 | 1.22 Million USD | 18.56% |
| 2020 Q3 | 1.36 Million USD | 16.71% |
| 2020 Q2 | 1.16 Million USD | -6.34% |
| 2020 Q1 | 1.24 Million USD | 16.34% |
| 2020 FY | 5.12 Million USD | -0.06% |
| 2020 Q4 | 1.34 Million USD | -1.17% |
| 2019 Q3 | 1.7 Million USD | 53.56% |
| 2019 FY | 5.12 Million USD | 68.17% |
| 2019 Q1 | 1.23 Million USD | 40.61% |
| 2019 Q2 | 1.11 Million USD | -10.11% |
| 2019 Q4 | 1.07 Million USD | -37.22% |
| 2018 Q1 | 524 Thousand USD | 19.91% |
| 2018 Q2 | 765 Thousand USD | 45.99% |
| 2018 Q3 | 879 Thousand USD | 14.9% |
| 2018 Q4 | 879 Thousand USD | 0.0% |
| 2018 FY | 3.04 Million USD | 65.42% |
| 2017 Q3 | 609 Thousand USD | 14.69% |
| 2017 FY | 1.84 Million USD | 119.81% |
| 2017 Q2 | 531 Thousand USD | 100.38% |
| 2017 Q1 | 265 Thousand USD | -46.79% |
| 2017 Q4 | 437 Thousand USD | -28.24% |
| 2016 Q1 | 48 Thousand USD | 201.01% |
| 2016 FY | 838 Thousand USD | 548.84% |
| 2016 Q4 | 498 Thousand USD | 69.97% |
| 2016 Q3 | 293 Thousand USD | 29400.0% |
| 2016 Q2 | -1000.00 USD | -102.08% |
| 2015 FY | 129.15 Thousand USD | -22.84% |
| 2015 Q4 | -47.52 Thousand USD | -171.67% |
| 2015 Q3 | 66.3 Thousand USD | 146.38% |
| 2015 Q2 | 26.91 Thousand USD | -67.76% |
| 2015 Q1 | 83.45 Thousand USD | -59.28% |
| 2014 Q2 | -37.96 Thousand USD | 30.73% |
| 2014 Q1 | -54.8 Thousand USD | 59.75% |
| 2014 Q4 | 204.96 Thousand USD | 271.33% |
| 2014 FY | 167.39 Thousand USD | 185.2% |
| 2014 Q3 | 55.19 Thousand USD | 245.39% |
| 2013 Q2 | -33.9 Thousand USD | 56.14% |
| 2013 FY | -196.47 Thousand USD | -230.83% |
| 2013 Q1 | -77.3 Thousand USD | -153.94% |
| 2013 Q4 | -136.16 Thousand USD | -367.48% |
| 2013 Q3 | 50.9 Thousand USD | 250.14% |
| 2012 Q1 | -20.42 Thousand USD | -108.74% |
| 2012 FY | 150.17 Thousand USD | -78.64% |
| 2012 Q3 | 185.9 Thousand USD | 217.2% |
| 2012 Q2 | -158.62 Thousand USD | -676.63% |
| 2012 Q4 | 143.32 Thousand USD | -22.9% |
| 2011 FY | 703.2 Thousand USD | -39.24% |
| 2011 Q3 | 204.22 Thousand USD | 2.68% |
| 2011 Q4 | 233.74 Thousand USD | 14.46% |
| 2011 Q1 | 66.34 Thousand USD | -85.47% |
| 2011 Q2 | 198.89 Thousand USD | 199.81% |
| 2010 Q1 | 215.6 Thousand USD | 15.81% |
| 2010 FY | 1.15 Million USD | 59.47% |
| 2010 Q2 | 127.91 Thousand USD | -40.67% |
| 2010 Q3 | 357.42 Thousand USD | 179.42% |
| 2010 Q4 | 456.47 Thousand USD | 27.71% |
| 2009 FY | 725.79 Thousand USD | 305.42% |
| 2009 Q1 | 218.99 Thousand USD | 618.94% |
| 2009 Q3 | 52.48 Thousand USD | -80.43% |
| 2009 Q4 | 186.15 Thousand USD | 254.68% |
| 2009 Q2 | 268.15 Thousand USD | 22.45% |
| 2008 Q2 | -397.52 Thousand USD | -658.74% |
| 2008 FY | -353.33 Thousand USD | -133.32% |
| 2008 Q1 | 71.14 Thousand USD | -81.33% |
| 2008 Q4 | -42.2 Thousand USD | -376.82% |
| 2008 Q3 | 15.24 Thousand USD | 103.84% |
| 2007 Q2 | -483.45 Thousand USD | -222.77% |
| 2007 Q1 | -149.78 Thousand USD | -1931.78% |
| 2007 Q4 | 381.13 Thousand USD | 278.64% |
| 2007 FY | -151.43 Thousand USD | -177.37% |
| 2007 Q3 | 100.66 Thousand USD | 120.82% |
| 2006 Q4 | -7372.00 USD | -103.91% |
| 2006 Q2 | 26.76 Thousand USD | 110.19% |
| 2006 Q1 | -262.7 Thousand USD | 53.86% |
| 2006 FY | -54.59 Thousand USD | 97.0% |
| 2006 Q3 | 188.71 Thousand USD | 605.19% |
| 2005 Q3 | -312.23 Thousand USD | 27.39% |
| 2005 Q2 | -430.02 Thousand USD | 15.56% |
| 2005 Q4 | -569.3 Thousand USD | -82.33% |
| 2005 FY | -1.82 Million USD | 0.0% |
| 2005 Q1 | -509.25 Thousand USD | 0.0% |
| 2004 Q2 | -390 Thousand USD | 0.0% |
| 2004 Q3 | -509.25 Thousand USD | -30.58% |
| 2004 Q1 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1997 FY | - USD | -100.0% |
| 1996 FY | 1.16 Million USD | 46.38% |
| 1995 FY | 795.6 Thousand USD | -3.24% |
| 1994 FY | 822.27 Thousand USD | 123.51% |
| 1993 FY | 367.89 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Electromed, Inc. | 41.72 Million USD | 96.084% |
| Senseonics Holdings, Inc. | 3.09 Million USD | 47.137% |
| Catheter Precision, Inc. | 412 Thousand USD | -296.602% |
| Xtant Medical Holdings, Inc. | 55.46 Million USD | 97.054% |